Hippocampal Atrophy Confounds Template-Based Functional MR Imaging Measures of Hippocampal Activation in Patients with Mild Cognitive Impairment

References

1. ↵
   Bookheimer SY, Strojwas MH, Cohen MS, et al. Patterns of brain activation in people at risk for Alzheimer’s disease. N Engl J Med 2000;343:450–56

   CrossRefPubMedWeb of Science
2. ↵
   Jack CR, Dickson DW, Parisi JE, et al. Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia. Neurology 2002;58:750–57

   Abstract/FREE Full Text
3. ↵
   Machulda MM, Ward HA, Borowski B, et al. Comparison of memory fMRI response among normal, MCI, and Alzheimer’s patients. Neurology 2003;61:500–06

   Abstract/FREE Full Text
4. ↵
   Dickerson BC, Salat DH, Bates JF, et al. Medial temporal lobe function and structure in mild cognitive impairment. Ann Neurol 2004;56:27–35

   CrossRefPubMedWeb of Science
5. ↵
   Meyer JS, Takashima S, Terayama Y, et al. CT changes associated with normal aging of the human brain. J Neurol Sci 1994;123:200–08

   CrossRefPubMed
6. ↵
   Karas GB, Scheltens P, Rombouts SA, et al. Global and local gray matter loss in mild cognitive impairment and Alzheimer’s disease. Neuroimage 2004;23:708–16

   CrossRefPubMedWeb of Science
7. ↵
   Galton CJ, Patterson K, Graham K, et al. Differing patterns of temporal atrophy in Alzheimer’s disease and semantic dementia. Neurology 2001;57:216–25

   Abstract/FREE Full Text
8. ↵
   Meltzer CC, Zubieta JK, Brandt J, et al. Regional hypometabolism in Alzheimer’s disease as measured by positron emission tomography after correction for effects of partial volume averaging. Neurology 1996;47:454–61

   Abstract/FREE Full Text
9. ↵
   Veltman DJ, Hutton C. SPM99 Manual. London, UK: Wellcome;2001
10. ↵
    Talairach J, Tournoux P. Co-planar stereotaxic atlas of the human brain: 3-dimensional proportional system. New York: Thieme Medical Publishers;1988
11. ↵
    Evans AC, Collins DL, Mills SR, et al. 3D statistical neuroanatomical models from 305 MRI volumes. In: IEEE-Nuclear Science Symposium and Medical Imaging Conference;1993
12. ↵
    Convit A, De Leon MJ, Tarshish C, et al. Specific hippocampal volume reductions in individuals at risk for Alzheimer’s disease. Neurobiol Aging 1997;18:131–38

    CrossRefPubMedWeb of Science
13. Killiany RJ, Gomez-Isla T, Moss M, et al. Use of structural magnetic resonance imaging to predict who will get Alzheimer’s disease. Ann Neurol 2000;47:430–39

    CrossRefPubMedWeb of Science
14. Dickerson BC, Goncharova I, Sullivan MP, et al. MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer’s disease. Neurobiol Aging 2001;22:747–54

    CrossRefPubMedWeb of Science
15. Pennanen C, Testa C, Laakso MP, et al. A voxel based morphometry study on mild cognitive impairment. J Neurol Neurosurg Psychiatry 2005;76:11–14

    Abstract/FREE Full Text
16. ↵
    Wolf H, Grunwald M, Kruggel F, et al. Hippocampal volume discriminates between normal cognition, questionable and mild dementia in the elderly. Neurobiol Aging 2001;22:177–86

    CrossRefPubMedWeb of Science
17. ↵
    Vandenbroucke MW, Goekoop R, Duschek EJ, et al. Interindividual differences of medial temporal lobe activation during encoding in an elderly population studied by fMRI. Neuroimage 2004;21:173–80

    CrossRefPubMedWeb of Science
18. ↵
    Johnson SC, Saykin AJ, Baxter LC, et al. The relationship between fMRI activation and cerebral atrophy: comparison of normal aging and Alzheimer disease. Neuroimage 2000;11:179–87

    CrossRefPubMedWeb of Science
19. ↵
    Petersen RC. Mild cognitive impairment clinical trials. Nat Rev Drug Discov 2003;2:646–53

    CrossRefPubMedWeb of Science
20. ↵
    Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303–08

    CrossRefPubMedWeb of Science
21. ↵
    Sperling RA, Bates JF, Cocchiarella AJ, et al. Encoding novel face-name associations: a functional MRI study. Hum Brain Mapp 2001;14:129–39

    CrossRefPubMedWeb of Science
22. ↵
    Sperling RA, Bates JF, Chua EF, et al. fMRI studies of associative encoding in young and elderly controls and mild Alzheimer’s disease. J Neurol Neurosurg Psychiatry 2003;74:44–50

    Abstract/FREE Full Text
23. ↵
    Martinez AM, Benavente R. The AR face database. CVC Technical Report 24,1998
24. ↵
    Gerig G, Yushkevich P, Ho S. ITK-SnAP [computer program]. Version 1.0. Chapel Hill, NC: Cognitica Corporation;2004
25. ↵
    Jack CR, Petersen RC, Xu YC, et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 1999;52:1397–403

    Abstract/FREE Full Text
26. ↵
    Laakso MP, Soininen H, Partanen K, et al. MRI of the hippocampus in Alzheimer’s disease: sensitivity, specificity, and analysis of the incorrectly classified subjects. Neurobiol Aging 1998;19:23–31

    CrossRefPubMedWeb of Science
27. ↵
    Frackowiak RSJ, Friston KJ, Frith CD, et al. Human Brain Function. San Diego, Calif: Academic Press;1997
28. ↵
    Saykin AJ, Wishart HA, Rabin LA, et al. Cholinergic enhancement of frontal lobe activity in mild cognitive impairment. Brain 2004;127:1574–83

    Abstract/FREE Full Text
29. ↵
    Goekoop R, Rombouts SARB, Jonker C, et al. Challenging the cholinergic system in mild cognitive impairment: a pharmacological fMRI study. Neuroimage 2004;23:1450–59

    CrossRefPubMedWeb of Science
30. ↵
    Dickerson BC, Salat DH, Greve DN, et al. Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. Neurology 2005;65:404–11

    Abstract/FREE Full Text
31. ↵
    Maldjian JA, Laurienti PJ, Burdette JH. Precentral gyrus discrepancy in electronic versions of the Talairach Atlas. Neuroimage 2004;21:450–55

    CrossRefPubMedWeb of Science
32. Maldjian JA, Laurienti PJ, Burdette JH, et al. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage 2003;19:1233–39

    CrossRefPubMedWeb of Science
33. ↵
    Tzourio-Mazoyer N, Landeau B, Papathanassiou D, et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002;15:273–89

    CrossRefPubMedWeb of Science
34. ↵
    Bondi MW, Houston WS, Eyler LT, et al. fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease. Neurology 2005;64:501–08

    Abstract/FREE Full Text
35. ↵
    De Leon MJ, George AE, Golomb J, et al. Frequency of hippocampal formation atrophy in normal aging and Alzheimer’s disease. Neurobiol Aging 1997;18:1–11

    PubMed
36. ↵
    Gao FQ, Black SE, Leibovitch FS, et al. Linear width of the medial temporal lobe can discriminate Alzheimer’s disease from normal aging: the Sunnybrook dementia study. Neurobiol Aging 2004;25:441–48

    CrossRefPubMedWeb of Science
37. ↵
    Krasnow B, Tamm L, Greicius M, et al. Comparison of fMRI activation at 3 and 1.5 T during perceptual, cognitive, and affective processing. Neuroimage 2003;18:813–26

    CrossRefPubMedWeb of Science
38. ↵
    Krishnan S, Slavin MJ, Tran TT, et al. Accuracy of spatial normalization of the hippocampus: Implications for fMRI research in memory disorders. NeuroImage 2006;31:560–71

    CrossRefPubMedWeb of Science